Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBurning Rock Biotech Limited Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$10.80 | -$10.80 | -$10.80 |
| Q2 2024 | 1 | -$9.89 | -$9.89 | -$9.89 |
| Q3 2024 | 1 | -$10.20 | -$10.20 | -$10.20 |
Burning Rock Biotech Limited Earnings Date And Information
Burning Rock Biotech Limited last posted its earnings results on Tuesday, December 3rd, 2024. The company reported $-0.5 earnings per share for the quarter, topping analysts' consensus estimates of $-1.41035 by $0.91035. The company had revenue of 128.64 M for the quarter and had revenue of 537.44 M for the year. Burning Rock Biotech Limited has generated $-64 earnings per share over the last year ($-63.84 diluted earnings per share) and currently has a price-to-earnings ratio of -1.15. Burning Rock Biotech Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.
Burning Rock Biotech Limited Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 12/04/2024 | Q3 2024 | -$3.46 | $128.64 M | $128.64 M | ||
| 08/23/2024 | Q2 2024 | -$10.53 | $135.53 M | $135.53 M | ||
| 03/28/2024 | Q1 2024 | -$11.85 | $125.62 M | |||
| 11/30/2023 | Q4 2023 | -$1.58 | $121.09 M | |||
| 09/05/2023 | Q3 2023 | -$1.71 | $198.02 M | $127.57 M | ||
| 05/30/2023 | Q2 2023 | -$2.00 | -$1.28 | 0.72 | $172.74 M | $146.27 M |
| 03/28/2023 | Q1 2023 | -$0.38 | -$1.81 | -1.43 | $142.52 M | |
| 11/16/2022 | Q4 2022 | -$2.11 | $142.24 M | |||
| 08/31/2022 | Q3 2022 | -$3.60 | -$2.18 | 1.42 | $154.05 M | $154.63 M |
| 05/31/2022 | Q2 2022 | -$2.30 | -$2.50 | -0.2 | $151.98 M | $130.85 M |
| 03/22/2022 | Q1 2022 | -$2.47 | $135.52 M | |||
| 11/16/2021 | Q4 2021 | -$2.40 | $147.35 M | |||
| 08/31/2021 | Q3 2021 | -$1.50 | -$1.64 | -0.14 | $129.08 M | $126.62 M |
| 05/25/2021 | Q2 2021 | -$1.40 | -$1.96 | -0.56 | $139.09 M | $127.28 M |
| 03/11/2021 | Q1 2021 | -$1.65 | $106.62 M | |||
| 11/20/2020 | Q4 2020 | -$1.10 | -$1.51 | -0.41 | $131.72 M | |
| 08/11/2020 | Q3 2020 | -$2.00 | -$1.22 | 0.78 | $115.51 M | $123.88 M |
| 08/11/2020 | Q2 2020 | -$2.00 | -$1.74 | 0.26 | $94.18 M | $106.97 M |
| 03/30/2020 | Q1 2020 | -$0.52 | $67.33 M | |||
| 12/30/2019 | Q4 2019 | -$1.10 | $88.68 M |
Burning Rock Biotech Limited Earnings: FAQ's
When is Burning Rock Biotech Limited's earnings date?
Burning Rock Biotech Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based off last year's report dates.
Did Burning Rock Biotech Limited beat their earnings estimates last
quarter?
In the previous quarter, Burning Rock Biotech Limited (:BNR) reported $-0.5 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.41035 by $0.91035.
How can I listen to Burning Rock Biotech Limited's earnings conference
call?
The conference call for Burning Rock Biotech Limited's latest earnings report can be listened to online.
How can I read Burning Rock Biotech Limited's conference call transcript?
The conference call transcript for Burning Rock Biotech Limited's latest earnings report can be read online.
How much revenue does Burning Rock Biotech Limited generate each year?
Burning Rock Biotech Limited (:BNR) has a recorded annual revenue of $537.44 M.
How much profit does Burning Rock Biotech Limited generate each year?
Burning Rock Biotech Limited (:BNR) has a recorded net income of $537.44 M. Burning Rock Biotech Limited has generated $-63.84 earnings per share over the last four quarters.
What is Burning Rock Biotech Limited's price-to-earnings ratio?
Burning Rock Biotech Limited (:BNR) has a price-to-earnings ratio of -1.15 and price/earnings-to-growth ratio is 0.17.